Bioavailability
Bioavailability refers to the proportion of a compound that reaches systemic circulation in its active form after administration. For peptides, oral bioavailability is typically very low (<1-2%) due to enzymatic degradation in the gastrointestinal tract and poor membrane permeability.
Factors affecting peptide bioavailability include: molecular weight (larger peptides are less permeable), enzymatic stability (susceptibility to proteases), lipophilicity, and route of administration. Modifications like fatty acid conjugation (as in semaglutide's C-18 fatty diacid linker) can enhance bioavailability by enabling albumin binding.
All Healthy Aminos products are for research use only.
Related Products
Related Terms
Half-Life
The time required for the concentration of a compound to decrease by 50%, a key pharmacokinetic parameter in peptide research.
Receptor Agonist
A molecule that binds to and activates a receptor, mimicking the action of the natural ligand to initiate a signaling response.
Cyclization
The formation of a ring structure within a peptide, typically through side-chain-to-side-chain, head-to-tail, or disulfide linkages, often increasing metabolic stability.
Research Use Only
FOR RESEARCH USE ONLY. Products sold by Healthy Aminos are intended strictly for in-vitro research and laboratory use. Not for human or animal consumption. Not FDA approved. By purchasing from Healthy Aminos, the buyer acknowledges that these products are not intended to diagnose, treat, cure, or prevent any disease. All products are sold as reference standards and research chemicals only.